Currently not seeking CRO, CDMO services.
Ziphius, a Belgium/US-based private biotech company, is advancing a next-generation platform utilizing self-amplifying RNA (saRNA) and lipid nanoparticles (LNPs) to develop first and best in class vaccines/medicines for infectious diseases, rare diseases, and oncology.
